Ovarian cancer and long-term tamoxifen in premenopausal women - PubMed (original) (raw)

Ovarian cancer and long-term tamoxifen in premenopausal women

D V Spicer et al. Lancet. 1991.

No abstract available

PubMed Disclaimer

Similar articles

• Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.
  Swerdlow AJ, Jones ME. Swerdlow AJ, et al. Br J Cancer. 2007 Mar 12;96(5):850-5. doi: 10.1038/sj.bjc.6603605. Epub 2007 Feb 6. Br J Cancer. 2007. PMID: 17285129 Free PMC article.
• Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
  Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR. Cook LS, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64. doi: 10.1093/jnci/87.18.1359. J Natl Cancer Inst. 1995. PMID: 7658496
• Tamoxifen to prevent breast cancer.
  Baum M, Houghton J, Riley D. Baum M, et al. Lancet. 1991 Jul 13;338(8759):114. doi: 10.1016/0140-6736(91)90104-w. Lancet. 1991. PMID: 1676439 Clinical Trial. No abstract available.
• Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
  Jankowitz RC, McGuire KP, Davidson NE. Jankowitz RC, et al. Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032. Breast. 2013. PMID: 24074781 Review.
• Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
  Nourmoussavi M, Pansegrau G, Popesku J, Hammond GL, Kwon JS, Carey MS. Nourmoussavi M, et al. Cancer Treat Rev. 2017 Apr;55:26-35. doi: 10.1016/j.ctrv.2017.02.005. Epub 2017 Feb 22. Cancer Treat Rev. 2017. PMID: 28288389 Review.

Cited by

• Medical hypothesis: xenoestrogens as preventable causes of breast cancer.
  Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Davis DL, et al. Environ Health Perspect. 1993 Oct;101(5):372-7. doi: 10.1289/ehp.93101372. Environ Health Perspect. 1993. PMID: 8119245 Free PMC article. Review.
• The Effect of Tamoxifen Citrate on Granulosa Cells of Ovarian Follicles in Adult Female Rats: Light Microscopic Study.
  Aljassim FK, El-Sheikh AA, Motabagani MA. Aljassim FK, et al. J Microsc Ultrastruct. 2022 Nov 9;12(1):1-5. doi: 10.4103/jmau.jmau_79_21. eCollection 2024 Jan-Mar. J Microsc Ultrastruct. 2022. PMID: 38633571 Free PMC article.
• Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.
  Swerdlow AJ, Jones ME. Swerdlow AJ, et al. Br J Cancer. 2007 Mar 12;96(5):850-5. doi: 10.1038/sj.bjc.6603605. Epub 2007 Feb 6. Br J Cancer. 2007. PMID: 17285129 Free PMC article.
• Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
  Ting AY, Kimler BF, Fabian CJ, Petroff BK. Ting AY, et al. Cancer Prev Res (Phila). 2008 Dec;1(7):546-53. doi: 10.1158/1940-6207.CAPR-08-0015. Cancer Prev Res (Phila). 2008. PMID: 19139004 Free PMC article.
• Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.
  Cohen I, Rosen DJ, Altaras M, Beyth Y, Shapira J, Yigael D. Cohen I, et al. Br J Cancer. 1994 Mar;69(3):620-1. doi: 10.1038/bjc.1994.116. Br J Cancer. 1994. PMID: 8123501 Free PMC article. Clinical Trial. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information